JESSICA HURLOCKER: Open Payments
NPI 1073229076 · BILLINGS, MT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$115 in 7 payments from 5 companies in 2025. Trend: 2023 $31 · 2024 $53 · 2025 $115
Food & beverage: $115
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 2 | $35 |
| Janssen Pharmaceuticals, Inc | 2 | $30 |
| Supernus Pharmaceuticals, Inc. | 1 | $20 |
| Vanda Pharmaceuticals Inc. | 1 | $15 |
| Teva Pharmaceuticals USA, Inc. | 1 | $14 |
Products named: INGREZZA, Qelbree, INVEGA, FANAPT, AUSTEDO XR, INVEGA SUSTENNA.
Industry payments across MT — which companies pay providers there.
